The role of ethnicity, age and gender in venous thromboembolism

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 4, 2010, Pages 489-496

  Montagnana, Martina ^a   Favaloro, Emmanuel J ^b   Franchini, Massimo ^a   Guidi, Gian Cesare ^a   Lippi, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Age; Ethnicity; Gender; Thrombosis; Venous thromboembolism

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CYTOCHROME P450 2C9; D DIMER; PROTEIN S; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; WARFARIN;

AFRICAN AMERICAN; AGE; ASIAN; CARDIOVASCULAR RISK; CAUCASIAN; DEEP VEIN THROMBOSIS; ETHNIC DIFFERENCE; ETHNICITY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; LUNG EMBOLISM; NEGRO; NONHUMAN; PHARMACOGENETICS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; VENOUS THROMBOEMBOLISM; ADOLESCENT; ADULT; AGED; ETHNOLOGY; FEMALE; MALE; MIDDLE AGED; MORTALITY; RACE; SEXUAL DEVELOPMENT; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTORS; SEX CHARACTERISTICS; SEX FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 77955491421     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0365-8     Document Type: Review

References (107)

1. Ageno W, Squizzato A, Garcia D, Imberti D (2006) Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 32:651-658. doi:10.1055/s-2006-951293 (Pubitemid 44623373)
2. Lippi G, Franchini M (2008) Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 34:747-761. doi:10.1055/s-0029-1145257
3. Lippi G, Franchini M, Montagnana M, Guidi GC (2007) Genomics and proteomics in venous thromboembolism: building a bridge toward a rational personalized medicine framework. Semin Thromb Hemost 33:759-770. doi:10.1055/s-2007-100 0366
4. Bonner L, Coker E, Wood L (2008) Preventing venous thromboembolism through risk assessment approaches. Br J Nurs 17:778-782
5. Heit JA (2006) The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 21:23-29. doi:10.1007/s11239-006-5572-y (Pubitemid 43231124)
6. White RH (2003) The epidemiology of venous thromboembolism. Circulation 107 (23 Suppl 1): I4-I8. doi:10.1161/01. CIR. 0000078468.11849.66
7. Itakura H (2005) Racial disparities in risk factors for thrombosis. Curr Opin Hematol 12:364-369. doi:10.1097/01.moh.0000167 746.26145.53
8. Klatsky AL, Baer D (2004) What protects Asians from venous thromboembolism? Am J Med 116:493-495. doi:10.1016/j.amjmed.2004.01.005 (Pubitemid 38388621)
9. White RH, Zhou H, Romano PS (1998) Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128:737-740
10. White RH, Zhou H, Murin S, Harvey DE (2005) Effect ofethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93:298-305
11. Keenan CR, White RH (2007) The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 13:377-383
12. Lippi G, Franchini M, Favaloro EJ (2009) Pharmacogenetics of vitamin K antagonists: useful or hype? Clin Chem Lab Med (in press)
13. Cheuk BL, Cheung GC, Cheng SW (2004) Epidemiology of venous thromboembolism in a Chinese population. Br J Surg 91:424-428. doi:10.1002/bjs.4454 (Pubitemid 38491110)
14. Kishimoto M, Lim HY, Tokuda Y et al (2005) Prevalence of venous thromboembolism at a teaching hospital in Okinawa, Japan. Thromb Haemost 93:876-879
15. Dhillon KS, Askander A, Doraisamy S (1996) Postoperative deepvein thrombosis in Asian patients is not a rarity. J Bone Joint Surg Br 78:427-430
16. Mok CK, Hoaglund FT, Rogoff SM et al (1979) The incidence of deep vein thrombosis in Hong Kong Chinese after hip surgery for fracture of the proximal femur. Br J Surg 66:640-642. doi: 10.1002/bjs.1800660914 (Pubitemid 10224296)
17. Jun. ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W (2006) Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol 28:111-116. doi:10.1111/j.1365-2257.2006.00757.x
18. Fujimura H, Kambayash J, Monden M et al (1995) Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost 74:1381-1382
19. Shen MC, Lin JS, Tsay W (1997) High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res 87:377-385. doi:10.1016/S0049-3848 (97) 00141-2
20. Angchaisuksiri P, Atichartakarn V, Aryurachai K, Archararit N, Rachakom B, Atamasirikul K, Tiraganjana A (2007) Risk factors of venous thromboembolism in thai patients. Int J Hematol 86:397-402. doi:10.1007/BF02983995
21. Kim TM, Kim JS, Han SW, et al. (2008) Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea. Thromb Res 123:436-443
22. Bertina RM, Koeleman BP, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67. doi:10.1038/369064a0 (Pubitemid 24144355)
23. Biswas A, Bajaj J, Ranjan R et al (2008) Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis? Clin Chim Acta 392:21-24. doi:10.1016/j.cca.2008.02.018
24. Chuansumrit A, Jarutwachirakul W, Sasanakul W, Rurgkhum S, Kadegasem P, Kitpoka P, Sirachainan N (2004) Absence of factor V arg306-thr and low factor V arg306->gly mutation prevalence in Thai blood donors. Southeast Asian J Trop Med Public Health 35:450-452
25. Tanaka K, Davie EW, Ikeda Y, Iwanaga S, Saito H, Sueishi K (2008) Clinical role of protein S deficiency in Asian population. In: Tanaka K, Davie EW (eds) Recent advances in thrombosis and hemostasis. Springer, USA, pp 597-613
26. Shen MC, Lin JS, Tsay W (2000) Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res 99:447-452. doi:10.1016/S0049-3848 (00) 00265-6
27. Akkawat B, Rojnuckarin P (2005) Protein Sdeficiencyiscommon in a healthy Thai population. J Med Assoc Thai 88 (Suppl 4): S249-S254
28. Ko L, Hsu LA, Hsu TS et al (2006) Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population. Hum Genet 119:84-91. doi:10.1007/s00439-005-0102-0
29. Kimura R, Honda S, Kawasaki T et al (2006) Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood 107:1737-1738. doi:10.1182/blood-2005-09-3892 (Pubitemid 43242422)
30. Kinoshita S, Iida H, Inoue S et al (2005) Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 38:908-915. doi:10.1016/j.clinbiochem.2005.05.006 (Pubitemid 41316649)
31. Miyata T, Sato Y, Ishikawa J, et al. (2008) Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis. Thromb Res 124:14-18
32. Mokdad AH, Ford ES, Bowman BA et al (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79. doi:10.1001/jama.289.1.76 (Pubitemid 36026281)
33. Mok CC, Tang SS, To CH, Petri M (2005) Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 52:2774-2782. doi:10.1002/art.21224 (Pubitemid 41369106)
34. Uthman I, Khamashta M (2005) Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann Rheum Dis 64:1671-1676. doi:10.1136/ard.2005.038448 (Pubitemid 41667138)
35. Ferdinand KC (2008) Cardiovascular disease in blacks: can we stop the clock? J Clin Hypertens (Greenwich) 10:382-389. doi: 10.1111/j.1751-7176.2008. 07918.x
36. Patel RK, Ford E, Thumpston J et al (2003) Risk factors for venous thrombosis in the black population. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. Thromb Haemost 90:835-888
37. Miller CH, Dilley A, Richardson L et al (2001) Population differences in von Willebrand factor levels affect the diagnosis of von Willebrands disease in African-American women. Am J Hematol 67:125-129. doi:10.1002/ajh.1090 (Pubitemid 32423851)
38. O'Donnell J, Laffan MA (2001) The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 11:343-351. doi:10.1046/j.1365-3148.2001. 00315.x
39. Cox Gill JC, Endres-Brooks J, Bauer PJ et al (1987) The effect of ABO blood group in the diagnosis of von Willebrand disease. Blood 69:1691-1695
40. Mwangi J (1999) Blood group distribution in an urban population of patient targeted blood donors. East Afr Med J 76:615-618
41. James A (2003) Allelic frequencies of thrombophilic polymorphisms among African-Americans. J Thromb Haemost 1 (suppl): P0946
42. Rasmussen-Torvik LJ, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Rosamond WD, Folsom AR (2007) The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res 121:1-7. doi: 10.1016/j.thromres.2007.02.008 (Pubitemid 350025992)
43. Carter AM, Catto AJ, Kohler HP, Ariens RA, Strickland MH, Grant PJ (2000) Alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 96:1177-1179
44. Hooper WC, Lally C, Austin H et al (1999) The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 116:880-886. doi:10.1378/chest.116.4.880 (Pubitemid 29491853)
45. Dilley A, Austin H, Hooper WC et al (1998) Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med 132:452-455. doi:10.1016/S0022-2143 (98) 90121-4
46. Rahimy MC, Krishnamoorthy R, Ahouignan G, Laffan M, Vulliamy T (1998) The 20210A allele of prothrombin is not found among sickle cell disease patients from West Africa. Thromb Haemost 79:444
47. Hooper WC, Roberts S, Dowling N, Austin H, Lally C, Whitsett C (2006) The prevalence of the prothrombin gene variant C20209T in African-Americans and Caucasians and lack of association with venous thromboembolism. Thromb Res 118:767-768. doi:10.1016/j.thromres.2005.12.001 (Pubitemid 44647097)
48. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC (2003) The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE study. J Thromb Haemost 1:80-87. doi:10.1046/j.1538-7836.2003.00031.x
49. Warshawsky I, Hren C, Sercia L et al (2002) Detection of a novel point mutation of the prothrombin gene at position 20209. Diagn Mol Pathol 11:152-156. doi:10.1097/00019606-20020 9000-00005
50. Kearon C (2001) Epidemiology of venous thromboembolism. Semin Vasc Med 1:7-26. doi:10.1055/s-2001-14668
51. Rees DC, Cox M, Clegg JB (1995) World distribution of factor V Leiden. Lancet 346:1133-1134. doi:10.1016/S0140-6736 (95) 91803-5
52. Svensson PJ, Zoller B, Mattiasson I, Dahlback B (1997) The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis. J Intern Med 241:379-385. doi: 10.1046/j.1365-2796.1997.124140000.x
53. Tosetto A, Missiaglia E, Gatto E, Rodeghiero F (1997) The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza thrombophilia and atherosclerosis. Thromb Haemost 78:859-863
54. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504-1508
55. Mikovic D, Rakicevic LJ, Kovac M, Radojkovic D (2000) Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance. Thromb Haemost 84:723-724
56. Djordjevic V, Rakicevic LJ, Mikovic D et al (2004) Prevalence of factor V Leiden, factor V Cambridge, factor II G20210A and methylenetetrahydrofolate reductase C677T mutations in healthy and thrombophilic Serbian populations. Acta Haematol 112:227-229. doi:10.1159/000081280 (Pubitemid 39541273)
57. Pecheniuk NM, Marsh NA, Walsh TP, Dale JL (1997) Use of first nucleotide change technology to determine the frequency of factor V Leiden in a population of Australian blood donors. Blood Coagul Fibrinolysis 8:491-495. doi:10.1097/00001721-199711000-00002
58. Dzimiri N, Meyer B (1996) World distribution of factor V Leiden. Lancet 347:481-482. doi:10.1016/S0140-6736 (96) 900 64-1
59. Poort RS, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703
60. Leroyer C, Mercier B, Oger E et al (1998) Prevalence of 20210A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 80:49-51
61. Rosendaal FR, Doggen CJ, Zivelin A et al (1998) Geographic distribution of the 20210G to A prothrombin variant. Thromb Haemost 79:706-708
62. Zalavras CG, Giotopoulou S, Dokou E et al (2003) Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. Int Angiol 22:55-57
63. Collaboration Homocysteine Lowering Trialists' (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 316:894-898
64. Tucker KL, Olson B, Bakun P, Dallal GE, Selhub J, Rosenberg IH (2004) Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial. Am J Clin Nutr 79:805-811
65. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340:1449-1454. doi:10.1056/NEJM199905133401901 (Pubitemid 29220543)
66. Mezzano D, Leighton F, Martinez C et al (2001) Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. Eur J Clin Nutr 55:444-451. doi:10.1038/sj.ejcn. 1601202
67. Steffen LM, Folsom AR, Cushman M, Jacobs DR Jr, Rosamond WD (2007) Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the longitudinal investigation of thromboembolism etiology. Circulation 115:188-195. doi:10.1161/CIRCULATIONAHA.106.641688 (Pubitemid 46105717)
68. Bergqvist D (2005) Geographical aspects of postoperative venous thromboembolism. J Thromb Haemost 3:26-27. doi: 10.1111/j.1538-7836.2004.01098.x (Pubitemid 41647111)
69. Ho CH, Chwang LC, Hwang BH (1995) The influence of high fat diet on the fibrinolytic activity. Thromb Res 77:201-208. doi:10.1016/0049-3848 (95) 91607-M
70. Hammerschmidt DE (1980) Szechwan purpura. N Engl J Med 302:1191-1193
71. Okuyama T, Shibata S, Hoson M (1986) Effect of oriental plant drugs on human platelet aggregation: III. Effect of Chinese drug "Xiebai" on human platelet aggregation. Planta Med 3:171-175. doi:10.1055/s-2007-969113 (Pubitemid 16088740)
72. Pomp ER, Rosendaal FR, Doggen CJ (2008) Alcohol consumption is associated with a decreased risk of venous thrombosis. Thromb Haemost 99:59-63
73. Jick H, Derby LE, Wald Myers M, Vasilakis C, Newton KM (1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 348:981-983. doi:10.1016/S0140-6736 (96) 07114-0
74. Goldhaber SZ, Grodstein F, Stampfer MJ et al (1997) A prospective study of risk factors for pulmonary embolism in women. JAMA 277:642-645. doi:10.1001/jama.277.8.642 (Pubitemid 27097428)
75. Eichinger S, Hron G, Bialonczyk C et al (2008) Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 168:1678-1683. doi:10.1001/archinte.168.15. 1678
76. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P (2006) Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 367:1075-1079. doi:10.1016/S0140-6736 (06) 68474-2
77. Samama MM (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160:3415-3420. doi:10.1001/archinte.160.22. 3415
78. Alikhan R, Cohen AT, Combe S et al (2004) Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study. Arch Intern Med 164:963-968. doi:10.1001/archinte.164.9.963 (Pubitemid 38581515)
79. Alikhan R, Spyropoulos AC (2008) Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease. Am J Med 121:935-942. doi:10.1016/j.amjmed.2008.05.045
80. Jansen JM, Lijfering WM, Sprenger HG, van der Meer J, van Pampus MG (2008) Venous thromboembolism in HIV-positive women during puerperium: a case series. Blood Coagul Fibrinolysis 19:95-97. doi:10.1097/MBC.0b013e3282f38c23
81. Austin H, Key NS, Benson JM, Lally C, Dowling NF, Whitsett C, Hooper WC (2007) Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 110:908-912. doi: 10.1182/blood-2006-11-057604 (Pubitemid 47267428)
82. Baccarelli A, Zanobetti A, Martinelli I et al (2007) Effects of exposure to air pollution on blood coagulation. J Thromb Haemost 5:252-260. doi:10.1111/j.1538-7836.2007.02300.x (Pubitemid 46139447)
83. Baccarelli A, Martinelli I, Zanobetti A et al (2008) Exposure to particulate air pollution and risk of deep vein thrombosis. Arch Intern Med 168:920-927. doi:10.1001/archinte.168.9.920 (Pubitemid 351679631)
84. Dalen JE (2008) Particulate air pollution exposure and risk of venous thromboembolism. Arch Intern Med 168:2497. doi: 10.1001/archinternmed.2008.531
85. Lippi G, Favaloro EJ, Franchini M, Guidi GC (2008) Air pollution and coagulation testing: a new source of biological variability? Thromb Res 123:50-54. doi:10.1016/j.thromres.2008. 04.010
86. Baccarelli A, Zanobetti A, Martinelli I et al (2007) Air pollution, smoking, and plasma homocysteine. Environ Health Perspect 115:176-181
87. Keenan CR, White RH (2005) Age as a risk factor for venous thromboembolism after major surgery. Curr Opin Pulm Med 11:398-402. doi:10.1097/01.mcp. 0000174246.15386.69
88. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr (1994) The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 154:861-866. doi:10.1001/archinte.154.8.861 (Pubitemid 24135768)
89. Nowak-Göttl U, Kosch A (2004) Factor VIII, D-dimer, and thromboembolism in children. N Engl J Med 351:1051-1053. doi:10.1056/NEJMp048150 (Pubitemid 39167508)
90. Kosch A, Koch HG, Heinecke A, Kurnik K, Heller C, Nowak-Göttl U, Childhood Thrombophilia Study Group (2004) Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost 91:308-314
91. Bailey AL, Scantlebury DC, Smyth SS (2009) Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol 29:284-288. doi:10.1161/ATVBAHA. 108.179788
92. Zuern CS, Lindemann S, Gawaz M (2009) Platelet Function and Response to Aspirin: Gender-specific features and implications for female thrombotic risk and management. Semin Thromb Hemost, 35, (in press)
93. Anderson FA Jr, Wheeler HB, Goldberg RJ et al (1991) A population-based perspective of the hospital incidence and casefatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med 151:933-938. doi: 10.1001/archinte.151.5.933
94. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232:155-160
95. Proctor MC, Wainess RM, Henke PK, Upchurch GR, Wakefield TW (2004) Venous thromboembolism: regional differences in the nationwide inpatient sample, 1993 to 2000. Vascular 12:374-380. doi:10.2310/6670.2004.00037
96. Oger E (2000) Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBP study group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 83:657-660
97. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585-593. doi:10.1001/archinte. 158.6.585
98. Romero A, Alonso C, Rincón M et al (2005) Risk of venous thromboembolic disease in women a qualitative systematic review. Eur J Obstet Gynecol Reprod Biol 121:8-17. doi:10.1016/j.ejogrb.2004.11.023 (Pubitemid 40884630)
99. Moores L, Bilello KL, Murin S (2004) Sex and gender issues and venous thromboembolism. Clin Chest Med 25:281-297. doi:10.1016/j.ccm.2004.01.013 (Pubitemid 38507648)
100. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ (2008) Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 6:632-637. doi:10.1111/j.1538-7836.2008.02921.x (Pubitemid 351404930)
101. Cushman M, Kuller LH, Prentice R, Women'sHealth Initiative Investigators et al (2004) Estrogen plus progestin and risk of venous thrombosis. JAMA 292:1573-1580. doi:10.1001/jama. 292.13.1573
102. Battaglioli T, Martinelli I (2007) Hormone therapy and thromboembolic disease. Curr Opin Hematol 14:488-493
103. Kyrle P, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S (2004) The risk of recurrent venous thromboembolism in men and women. N Engl J Med 350:2558-2563. doi: 10.1056/NEJMoa032959 (Pubitemid 38765133)
104. Baglin T, Luddington R, Brown K, Baglin C (2004) High risk of recurrent venous thromboembolism in men. J Thromb Haemost 2:2152-2155. doi:10.1111/j.1538-7836.2004.01050.x (Pubitemid 40185775)
105. McRae S, Tran H, Schulman S, Ginsberg J, Kearon C (2006) Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 368:371-378. doi:10.1016/S0140-6736 (06) 69110-1
106. White RH, Dager WE, Zhou H, Murin S (2006) Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 96:267-273
107. Guidi GC, Lippi G (2009) Will "personalized medicine" need personalized laboratory approach? Clin Chim Acta 400:25-29. doi:10.1016/j.cca. 2008.09.029